Manjunath Markandaya, MD
Neurocritical Care · Gainesville, GANPI 1215101514
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $9,785 of the $11,781 with a category attached, or 83.1%. 14 manufacturers reported payments, led by AstraZeneca at 58.8% of the total. Reporting peaked in 2021 at $6,431 and has fallen 99.6% since, to $23 in 2024.
Across 52 payments — averaging $226.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$7K
- Portola Pharmaceuticals, LLC$3K
- Penumbra, Inc.$575
- Medtronic$395
- Irras USA, Inc.$360
- Johnson & Johnson$196
- plus $429 from 8 others
What the payments were for
- Speaking & faculty fees$9,78583%
- Travel & lodging$550%
- Food & beverage$1,94116%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $6,927 |
| Portola Pharmaceuticals, LLC | 8 | $2,899 |
| Penumbra, Inc. | 5 | $575 |
| Medtronic | 3 | $395 |
| Irras USA, Inc. | 2 | $360 |
| Johnson & Johnson | 2 | $196 |
| Baxter Healthcare | 1 | $131 |
| La Jolla Pharmaceutical Company | 9 | $125 |
| Chiesi USA, Inc. | 6 | $79 |
| UCB, Inc. | 2 | $28 |
| Laborie Medical Technologies Corp. | 1 | $23 |
| AbbVie | 1 | $18 |
| CSL Behring | 1 | $14 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ANDEXXA$9,400
- IRRAflow$352
- MIDAS REX$256
- REAL System$155
- SOLIRIS$150
- Solitaire$139
- Renal - Non Product Related$131
- Smart Coil$125
- EMBOTRAP II Revascularization Device$121
- Jet 7$109
- Penumbra System$100
How this compares
Too few neurocritical care providers in Georgiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurocritical care in Gainesville
- Andres RuizGainesville$486
- Ahmed JavedGainesville$170
- Ahmed FathyGainesville$117
- Gurkeerat SinghGainesville$102
- Samuel TsappidiAugusta$54K
- Manan ShahAugusta$3K
- Anand SarmaAtlanta$2K
- Klepper GarciaAugusta$997
- Christopher HornMarietta$897
- Anantha VellipuramAtlanta$361
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.